JESSICA WILSON: Open Payments
NPI 1952597585 · BEATTYVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 31 payments from 10 companies in 2025. Trend: 2023 $500 · 2024 $971 · 2025 $550
Food & beverage: $550
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 8 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $59 |
| ABBVIE INC. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| Amgen Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $39 |
| Arcutis Biotherapeutics, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $14 |
Products named: TRELEGY ELLIPTA, Kerendia, JARDIANCE, CAPLYTA, OTEZLA, MOUNJARO, VRAYLAR, Zoryve.
Industry payments across KY — which companies pay providers there.
